Is Viridian Therapeutics, Inc. VRDN stock halal to invest in?

No, as of February 2026, Viridian Therapeutics, Inc. stock (VRDN) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Viridian Therapeutics, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Viridian Therapeutics, Inc. and alternative halal stock options within the Tabadulat app.

How often is Viridian Therapeutics, Inc. VRDN reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Viridian Therapeutics, Inc. VRDN monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Viridian Therapeutics, Inc. VRDN pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Viridian Therapeutics, Inc. stock (VRDN) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Viridian Therapeutics, Inc. VRDN pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Viridian Therapeutics, Inc. stock (VRDN) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Viridian Therapeutics, Inc. stock (VRDN) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Viridian Therapeutics, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

VRDN

About

Viridian Therapeutics, Inc.

VRDN

Viridian Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies to treat patients suffering from serious and rare diseases. The company's primary aim is to leverage innovative science to address unmet medical needs, particularly in the field of endocrinology. Viridian Therapeutics Inc. is notable for its work on therapies targeting conditions such as thyroid eye disease (TED), where few effective treatments exist. The firm employs advanced research and development techniques to enhance therapeutic outcomes, pushing the envelope in biopharmaceutical innovation. Viridian's efforts contribute significantly to the healthcare sector by expanding treatment options in rare diseases, ultimately seeking to improve patient quality of life. The company's presence in the market underscores the importance of specialized therapeutic development, offering potential pathways for breakthroughs in medical treatment and broadening the scope of available biopharmaceutical interventions.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

143

Website:

https://www.viridiantherapeutics.com

VRDN

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Viridian Therapeutics, Inc.

About

Viridian Therapeutics, Inc.

VRDN

Frequently asked questions

Is Viridian Therapeutics, Inc. VRDN stock halal to invest in?

How often is Viridian Therapeutics, Inc. VRDN reviewed for Shariah compliance?

Does Viridian Therapeutics, Inc. VRDN pass the AAOIFI Non Permissible Income criteria?

Does Viridian Therapeutics, Inc. VRDN pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Viridian Therapeutics, Inc. VRDN stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.